Background The impact of ABO incompatibility on the outcome of hematopoietic stem cell
transplantation (HSCT) is still debated. We report the results of a prospective, single-center …

A 26‐year‐old, blood group O bone marrow transplant recipient experienced a severe,
delayed hemolytic transfusion reaction 6 days following transplantation of marrow from his …

ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT) can be
complicated by poor red cell engraftment and hemolysis, both mediated by isoagglutinins …

Immune haemolysis as a result of minor ABO incompatibility is an underappreciated
complication of haematopoietic transplantation. The increased lymphoid content of …

Introduction The impact of ABO mismatch on outcomes following allo-HSCT remains
controversial. In this study, our aim is to define the effect of ABO mismatch on post-transplant …

ABO blood group antigen incompatibility (ABO mismatch) is not an obstacle to allogeneic
stem cell transplantation (allo‐SCT). However, the impact on clinical outcome after allo‐SCT …

Background How to choose an appropriate method to monitoring dynamic ABO chimera
post‐ABO‐incompatible HSCT is crucial to not only assess the status of erythroid …

ABO incompatibility is not considered a contraindication for hematopoietic stem cell
transplantation (HSCT). Approximately 30% of transplants from related donors and up to …

ABO incompatibility is not considered a contraindication for allogeneic haematopoietic stem
cell transplantation (HSCT) despite its association with several immunohaematological …

Immune hemolysis following ABO-mismatched stem cell or solid... : Current Opinion in
Hematology Immune hemolysis following ABO-mismatched stem cell or solid organ …